litlas
ログインアカウント作成

Seppo Lehto

1992–2022 年に発表

53
論文数
19,017
被引用数
51
h 指数
53
i10 指数

被引用数

Seppo Lehto の年別被引用数1978 年: 被引用 1 件1983 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 3 件1995 年: 被引用 11 件1996 年: 被引用 24 件1997 年: 被引用 21 件1998 年: 被引用 55 件1999 年: 被引用 79 件2000 年: 被引用 108 件2001 年: 被引用 123 件2002 年: 被引用 129 件2003 年: 被引用 165 件2004 年: 被引用 219 件2005 年: 被引用 183 件2006 年: 被引用 184 件2007 年: 被引用 189 件2008 年: 被引用 155 件2009 年: 被引用 125 件2010 年: 被引用 152 件2011 年: 被引用 106 件2012 年: 被引用 143 件2013 年: 被引用 134 件2014 年: 被引用 116 件2015 年: 被引用 82 件2016 年: 被引用 89 件2017 年: 被引用 98 件2018 年: 被引用 74 件2019 年: 被引用 347 件2020 年: 被引用 324 件2021 年: 被引用 300 件2022 年: 被引用 198 件2023 年: 被引用 139 件2024 年: 被引用 198 件2025 年: 被引用 103 件2026 年: 被引用 4 件1979〜1982 年は被引用が無いため表示していません1984〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,490 件、この内訳の 21.6%イギリス: 引用元論文 565 件、この内訳の 8.2%イタリア: 引用元論文 385 件、この内訳の 5.6%ドイツ: 引用元論文 307 件、この内訳の 4.4%中国: 引用元論文 298 件、この内訳の 4.3%フィンランド: 引用元論文 289 件、この内訳の 4.2%オーストラリア: 引用元論文 250 件、この内訳の 3.6%カナダ: 引用元論文 239 件、この内訳の 3.5%オランダ: 引用元論文 232 件、この内訳の 3.4%フランス: 引用元論文 223 件、この内訳の 3.2%スペイン: 引用元論文 220 件、この内訳の 3.2%スウェーデン: 引用元論文 216 件、この内訳の 3.1%
0%21.6%その他 31.7%

機関

分野

  • Medicine77.6%
  • Biochemistry, Genetics and Molecular Biology11.7%
  • Nursing3.4%
  • Immunology and Microbiology1.8%
  • Health Professions1.1%
  • Social Sciences1%
  • その他3.4%

トピック

  • Diabetes, Cardiovascular Risks, and Lipoproteins8%
  • Lipoproteins and Cardiovascular Health4.4%
  • Diabetes Treatment and Management4.2%
  • Acute Myocardial Infarction Research2.9%
  • Cardiovascular Function and Risk Factors2.8%
  • Cardiac Health and Mental Health2.8%
  • その他74.9%

共著者

全論文

検索で開く
  1. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

    著者: Steven M. Haffner, Seppo Lehto, Tapani Rönnemaa, Kalevi Pyörälà, Markku Laakso - New England Journal of Medicine 1998 被引用: 7,071

  2. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

    著者: Kornelia Kotseva, Guy De Backer, Dirk De Bacquer, Lars Rydén, Arno W. Hoes, Diederick E. Grobbee, Aldo P. Maggioni, Pedro Marques‐Vidal, Catriona Jennings, Ana Abreu, Carlos Aguíar, Jolita Badarienė, Jan Bruthans, Almudena Castro Conde, Renata Cífková, Jim Crowley, Kairat Davletov, Jaap W. Deckers, Delphine De Smedt, Johan De Sutter, Mirza Dilić, Marina Dolzhenko, Vilnis Dzērve, Andrejs Ērglis, Zlatko Fras, Dan Gaiță, Nina Gotcheva, Peter U. Heuschmann, Hosam Hasan‐Ali, Piotr Jankowski, Nebojša Lalić, Seppo Lehto, Dragan Lović, S. Mancas, Linda Mellbin, Davor Miličić, Erkin М Мirrakhimov, Р. Г. Оганов, Nana Pogosova, Željko Reiner, Stefan Störk, Lâle Tokgözoğlu, Costas Tsioufis, Duško Vulić, David Wood, on behalf of the EUROASPIRE Investigators* - European Journal of Preventive Cardiology 2019 被引用: 937

  3. Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

    著者: Guy De Backer, Piotr Jankowski, Kornelia Kotseva, Erkin М Мirrakhimov, Željko Reiner, Lars Rydén, Lâle Tokgözoğlu, David Wood, Dirk De Bacquer, Guy De Backer, Piotr Jankowski, Kornelia Kotseva, E. Mirrakhimov, Željko Reiner, Lars Rydén, Lâle Tokgözoğlu, David Wood, Dirk De Bacquer, Kornelia Kotseva, Guy De Backer, Ana Abreu, Carlos Aguíar, Jolita Badarienė, Jan Bruthans, A. Castro Conde, Renata Cífková, Jim Crowley, Kairat Davletov, Dirk De Bacquer, Delphine De Smedt, Johan De Sutter, Jaap W. Deckers, Mirza Dilić, М. М. Долженко, H. Druais, Vilnis Dzērve, Andrejs Ērglis, Zlatko Fras, D. Gaita, Nina Gotcheva, D.E. Grobbee, Viveca Gyberg, Hosam Hasan Ali, Peter U. Heuschmann, Arno W. Hoes, Piotr Jankowski, Nebojša Lalić, Seppo Lehto, Dragan Lović, Aldo P. Maggioni, S. Mancas, Pedro Marques‐Vidal, Linda Mellbin, Davor Miličić, E. Mirrakhimov, Р. Г. Оганов, Nana Pogosova, Željko Reiner, Lars Rydén, Martin Stagmo, Stefan Störk, Jouko Sundvall, Lâle Tokgözoğlu, Konstantinos Tsioufis, Duško Vulić, David Wood, David A. Wood, Kornelia Kotseva, Catriona Jennings, Agnieszka Adamska, S. Adamska, Lars Rydén, Linda Mellbin, J. Tuomilehto, Oliver Schnell, H. Druais, Edoardo Fiorucci, Myriam Glémot, Florian Larras, V. Missiamenou, Aldo P. Maggioni, C. Taylor, Teresa Ferreira, Katell Lemaitre, Dirk De Bacquer, Guy De Backer, Laura Råman, Jouko Sundvall, Daniel-Henri Desmedt, Johan De Sutter, Anne‐Marie Willems, Michel De Pauw, Pieter Vervaet, J. Bollen, E. Dekimpe, N. Mommen, G. Van Genechten, Paul Dendale, C A Bouvier, Patrick Chenu ほか 475 名 - Atherosclerosis 2019 被引用: 369

  4. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

    著者: Kornelia Kotseva, David Wood, Dirk De Bacquer, Guy De Backer, Lars Rydén, Catriona Jennings, Viveca Gyberg, Philippe Amouyel, Jan Bruthans, Almudena Castro Conde, Renata Cífková, Jaap W. Deckers, Johan De Sutter, Mirza Dilić, Maryna Dolzhenko, Andrejs Ērglis, Zlatko Fras, Dan Gaiță, Nina Gotcheva, John Goudevenos, Peter U. Heuschmann, Aleksandras Laucevičius, Seppo Lehto, Dragan Lović, Davor Miličić, David Moore, Evagoras Nicolaides, Р. Г. Оганов, Andrzej Pająk, Nana Pogosova, Željko Reiner, Martin Stagmo, Stefan Störk, Lâle Tokgözoğlu, Duško Vulić, on behalf of the EUROASPIRE Investigators - European Journal of Preventive Cardiology 2015 被引用: 1,004

  5. Medial Artery Calcification

    著者: Seppo Lehto, Leo Niskanen, Matti Suhonen, Tapani Rönnemaa, Markku Laakso - Arteriosclerosis Thrombosis and Vascular Biology 1996 被引用: 593

  6. Prediction of recurrent event in patients with coronary heart disease: the EUROASPIRE Risk Model

    著者: Dirk De Bacquer, Peter Ueda, Željko Reiner, Johan De Sutter, Delphine De Smedt, Dragan Lović, Nina Gotcheva, Zlatko Fras, Nana Pogosova, Erkin М Мirrakhimov, Seppo Lehto, Tomas Jernberg, Kornelia Kotseva, Lars Rydén, David Wood, Guy De Backer, the EUROASPIRE IV and V National Coordinators - European Journal of Preventive Cardiology 2020 被引用: 63

  7. Type 2 Diabetes as a “Coronary Heart Disease Equivalent”

    著者: Auni Juutilainen, Seppo Lehto, Tapani Rönnemaa, Kalevi Pyörälà, Markku Laakso - Diabetes Care 2005 被引用: 460

  8. Gender Difference in the Impact of Type 2 Diabetes on Coronary Heart Disease Risk

    著者: Auni Juutilainen, Saara Kortelainen, Seppo Lehto, Tapani Rönnemaa, Kalevi Pyörälà, Markku Laakso - Diabetes Care 2004 被引用: 434

  9. Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V

    著者: Giulia Ferrannini, Dirk De Bacquer, Guy De Backer, Kornelia Kotseva, Linda Mellbin, David Wood, Lars Rydén, EUROASPIRE V collaborators, Chris P Gale, Branko Beleslin, Andrzej Budaj, Ovidiu Chioncel, Nikolaos Dagres, Nicolas Danchin, David Erlinge, Jonathan Emberson, Michael Glikson, Alastair Gray, Meral Kayıkçıoğlu, Aldo P. Maggioni, Klaudia Vivien Nagy, Aleksandr Nedoshivin, Anna-Sonia Petronio, Jolien W. Roos‐Hesselink, Lars Wallentin, Uwe Zeymer, Kornelia Kotseva, Guy De Backer, Ana Abreu, Carlos Aguíar, Jolita Badarienė, Jan Bruthans, Almudena Castro Conde, Renata Cífková, Jim Crowley, Kairat Davletov, Dirk De Bacquer, Delphine De Smedt, Johan De Sutter, Jaap W. Deckers, Mirza Dilić, Maryna Dolzhenko, H. Druais, Vilnis Dzērve, Andrejs Ērglis, Zlatko Fras, Dan Gaiță, Nina Gotcheva, Diederick E. Grobbee, Viveca Gyberg, Hosam Hasan Ali, Peter U. Heuschmann, Arno W. Hoes, Piotr Jankowski, Nebojša Lalić, Seppo Lehto, Dragan Lović, S. Mancas, Pedro Marques‐Vidal, Linda Mellbin, Davor Miličić, Erkin М Мirrakhimov, Oganov Rg, Nana Pogosova, Željko Reiner, Lars Rydén, Martin Stagmo, Stefan Störk, Jouko Sundvall, Lâle Tokgözoğlu, Costas Tsioufis, Duško Vulić, David Wood, Arno W. Hoes, Catriona Jennings, Agnieszka Adamska, S. Adamska, L.J. Tuomilehto, Oliver Schnell, Laura Råman, Anne‐Marie Willems, Michel De Pauw, Pieter Vervaet, Jessa Ziekenhuis, J. Bollen, E. Dekimpe, N. Mommen, G. Van Genechten, Paul Dendale, Audrey Bouvier, Patrick Chenu, D. Huyberechts, Alexandre Persu, Alden Begić, Azra Durak-Nalbantić, Alen Džubur, N. Hadzibegic, Amer Iglica, S. Kapidjic, A. Osmanagic Bico ほか 424 名 - Diabetes Care 2020 被引用: 79

  10. High-Sensitivity C-Reactive Protein and Coronary Heart Disease Mortality in Patients With Type 2 Diabetes

    著者: Minna Soinio, Jukka Marniemi, Markku Laakso, Seppo Lehto, Tapani Rönnemaa - Diabetes Care 2006 被引用: 188

  11. Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease

    著者: Vanessa D. de Mello, Maria Lankinen, Ursula Schwab, Marjukka Kolehmainen, Seppo Lehto, Tuulikki Seppänen‐Laakso, Matej Orešič, Lea Pulkkinen, Matti Uusitupa, Arja T. Erkkilä - Diabetologia 2009 被引用: 179

  12. Fatty Fish Intake Decreases Lipids Related to Inflammation and Insulin Signaling—A Lipidomics Approach

    著者: Maria Lankinen, Ursula Schwab, Arja T. Erkkilä, Tuulikki Seppänen‐Laakso, Marja‐Leena Hannila, Hanna Mussalo, Seppo Lehto, Matti Uusitupa, Helena Gylling, Matej Orešič - PLoS ONE 2009 被引用: 142

  13. Serum Uric Acid Is a Strong Predictor of Stroke in Patients With Non–Insulin-Dependent Diabetes Mellitus

    著者: Seppo Lehto, Leo Niskanen, Tapani Rönnemaa, Markku Laakso - Stroke 1998 被引用: 417

  14. Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment

    著者: Ru-Dee Ting, Anthony Keech, Paul Drury, Mark W. Donoghoe, John Hedley, Alicia J. Jenkins, Timothy M. E. Davis, Seppo Lehto, David S. Celermajer, R. J. Simes, Kushwin Rajamani, K. G. Stanton, on behalf of the FIELD Study Investigators - Diabetes Care 2011 被引用: 118

  15. Trends in long-term prognosis after acute coronary syndrome

    著者: Marjo Piironen, Olavi Ukkola, Heikki V. Huikuri, Aki S. Havulinna, Heli Koukkunen, Juha Mustonen, Matti Ketonen, Seppo Lehto, Juhani Airaksinen, Y. Antero Kesäniemi, Veikko Salomaa - European Journal of Preventive Cardiology 2016 被引用: 107

  16. Potential for optimizing management of obesity in the secondary prevention of coronary heart disease

    著者: Dirk De Bacquer, Catriona Jennings, Erkin М Мirrakhimov, Dragan Lović, Jan Bruthans, Delphine De Smedt, Nina Gotcheva, M. N. Dolzhenko, Zlatko Fras, Nana Pogosova, Seppo Lehto, Hasan Hasan-Ali, Piotr Jankowski, Kornelia Kotseva, Guy De Backer, David Wood, Lars Rydén - European Heart Journal - Quality of Care and Clinical Outcomes 2021 被引用: 16

  17. Similarity of the Impact of Type 1 and Type 2 Diabetes on Cardiovascular Mortality in Middle-Aged Subjects

    著者: Auni Juutilainen, Seppo Lehto, Tapani Rönnemaa, Kalevi Pyörälà, Markku Laakso - Diabetes Care 2008 被引用: 195

  18. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology

    著者: On behalf of the EUROASPIRE Investigators, Viveca Gyberg, Dirk De Bacquer, Guy De Backer, Catriona Jennings, Kornelia Kotseva, Linda Mellbin, Oliver Schnell, Jaakko Tuomilehto, David Wood, Lars Rydén, Philippe Amouyel, Jan Bruthans, Almudena Castro Conde, Renata Cífková, Jaap W. Deckers, Johan De Sutter, Mirza Dilić, Maryna Dolzhenko, Andrejs Ērglis, Zlatko Fras, Dan Gaiță, Nina Gotcheva, John Goudevenos, Peter U. Heuschmann, Aleksandras Laucevičius, Seppo Lehto, Dragan Lović, Davor Miličić, David Moore, Evagoras Nicolaides, Р. Г. Оганов, Andrzej Pająk, Nana Pogosova, Željko Reiner, Martin Stagmo, Stefan Störk, Lâle Tokgözoğlu, Duško Vulić - Cardiovascular Diabetology 2015 被引用: 146

  19. Risk factors for major adverse cardiovascular events after the first acute coronary syndrome

    著者: Marjo Okkonen, Aki S. Havulinna, Olavi Ukkola, Heikki V. Huikuri, Arto Pietilä, Heli Koukkunen, Seppo Lehto, Juha Mustonen, Matti Ketonen, Juhani Airaksinen, Y. Antero Kesäniemi, Veikko Salomaa - Annals of Medicine 2021 被引用: 56

  20. The validity of the Finnish Hospital Discharge Register and Causes of Death Register data on coronary heart disease

    著者: Pia Pajunen, Heli Koukkunen, Matti Ketonen, T. Jerkkola, Pirjo Immonen-R ih, P??ivi K??rj??-Koskenkari, Markku M h nen, Matti Niemel, Kari Kuulasmaa, Pertti Palom auml ki, Juha Mustonen, Aapo Lehtonen, M Arstila, T. Vuorenmaa, Seppo Lehto, Heikki Miettinen, Jorma Torppa, Jaakko Tuomilehto, Y. Antero Kes niemi, Kalevi Py r l, Veikko Salomaa - European Journal of Cardiovascular Prevention & Rehabilitation 2005 被引用: 329

  21. Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study

    著者: Bente Kilhovd, Auni Juutilainen, Seppo Lehto, Tapani Rönnemaa, Peter A. Torjesen, Kristian F. Hanssen, Markku Laakso - Diabetologia 2007 被引用: 163

  22. Serum Zinc Level and Coronary Heart Disease Events in Patients With Type 2 Diabetes

    著者: Minna Soinio, Jukka Marniemi, Markku Laakso, Kalevi Pyörälà, Seppo Lehto, Tapani Rönnemaa - Diabetes Care 2007 被引用: 157

  23. Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications

    著者: Arja T. Erkkilä, Ursula Schwab, Vanessa D. de Mello, Tiina Lappalainen, Hanna Mussalo, Seppo Lehto, Virpi Kemi, Christel Lamberg‐Allardt, Matti Uusitupa - European Journal of Nutrition 2008 被引用: 83

  24. Impact of Diabetes on Mortality After the First Myocardial Infarction

    著者: Heikki Miettinen, Seppo Lehto, Veikko Salomaa, Markku Mähönen, Matti Niemelä, Steven M. Haffner, Kalevi Pyörälà, Jaakko Tuomilehto, The FINMONICA Myocardial Infarction Register Study Group - Diabetes Care 1998 被引用: 669